Xwell (XWEL) Asset Writedowns and Impairment (2018 - 2026)
Xwell (XWEL) posted Asset Writedowns and Impairment of -$6000.0 for Q1 2026, down 100.24% sequentially from $2.5 million in Q4 2025, and down 200.0% YoY from $6000.0 in Q1 2025.
Xwell (XWEL) Asset Writedowns and Impairment (2018 - 2026) Analysis & Trends
Xwell has reported Asset Writedowns and Impairment for 9 years, with the latest figure at -$6000.0 in Q1 2026.
- Quarterly Asset Writedowns and Impairment fell 200.0% year-over-year to -$6000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.5 million (up 91.55% YoY) and the FY2025 annual result came in at $2.5 million, up 48.24% from the prior year.
- Asset Writedowns and Impairment retreated to -$6000.0 in Q1 2026 per XWEL's latest filing, from $2.5 million in the prior quarter.
- Over five years, Asset Writedowns and Impairment peaked at $2.5 million in Q4 2025 and troughed at -$605000.0 in Q4 2022.
- A 5-year average of $642636.4 and a median of $398000.0 in 2024 frame the typical range for Asset Writedowns and Impairment.
- The sharpest annual moves came in 2023 and 2026: Asset Writedowns and Impairment jumped 472.07% in 2023, then plunged 200.0% in 2026.
- Over 5 years, Asset Writedowns and Impairment stood at -$605000.0 in 2022, then surged by 472.07% to $2.3 million in 2023, then slumped by 49.49% to $1.1 million in 2024, then surged by 121.9% to $2.5 million in 2025, then sank by 100.24% to -$6000.0 in 2026.
- According to Business Quant data, Asset Writedowns and Impairment over the past three periods registered -$6000.0, $2.5 million, and $6000.0 for Q1 2026, Q4 2025, and Q1 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn |
| 10 | Xwell | 8.44 Mn | -3.33 Mn | 2.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2,000.00 |
| Jun 30, 2026 | 2,000.00 |
| Mar 31, 2026 | -6,000.00 |
| Mar 31, 2026 | -6,000.00 |
| Dec 31, 2025 | 2.41 Mn |
| Dec 31, 2025 | 2.41 Mn |
| Sep 30, 2025 | 116,000.00 |
| Sep 30, 2025 | 116,000.00 |
| Mar 31, 2025 | 6,000.00 |
| Mar 31, 2025 | 6,000.00 |
| Dec 31, 2024 | 1.14 Mn |
| Dec 31, 2024 | 1.14 Mn |
| Sep 30, 2024 | -83,000.00 |
| Sep 30, 2024 | -83,000.00 |
| Jun 30, 2024 | 254,000.00 |
| Jun 30, 2024 | 254,000.00 |
| Mar 31, 2024 | 398,000.00 |
| Mar 31, 2024 | 398,000.00 |
| Dec 31, 2023 | -5.63 Mn |
| Dec 31, 2023 | -5.63 Mn |